Leptotrichia菌血症:10年回顾性临床分析与抗菌药物敏感性谱
该研究回顾了Mayo Clinic Rochester的26例成人Leptotrichia血流感染患者,并分析了10年间参考实验室的224株分离株。最常见菌种为L. trevisanii(49%)、L. buccalis(24%)和L. wadei(16%)。分离株对青霉素、甲硝唑、厄他培南和哌拉西林-他唑巴坦敏感率>90%,但96%(74/77)对莫西沙星耐药。患者均中性粒细胞减少,60天全因死亡率为19%,无微生物学复发。
要点
- Leptotrichia血流感染罕见但重要,多见于中性粒细胞减少患者。
- 分离株对青霉素、甲硝唑、厄他培南和哌拉西林-他唑巴坦敏感率>90%。
- 96%(74/77)的分离株对莫西沙星耐药,选择治疗时需参考药敏结果。
核心结论
- Leptotrichia菌种是中性粒细胞减少患者血流感染的罕见但重要原因。
- 由于抗菌药物敏感性谱不断演变,选择最佳抗菌治疗时必须审查药敏试验结果。
研究设计与样本
- 回顾性队列研究,评估Mayo Clinic Rochester的26例成人Leptotrichia血流感染患者。
- 同时分析过去10年提交至Mayo Clinic Laboratories的Leptotrichia分离株的菌种、时间趋势和药敏试验结果。
- 共鉴定224株血培养Leptotrichia分离株,其中26株来自Mayo Clinic Rochester治疗的患者。
主要发现
- 最常见菌种为L. trevisanii(49%)、L. buccalis(24%)和L. wadei(16%)。
- Leptotrichia菌种对青霉素、甲硝唑、厄他培南和哌拉西林-他唑巴坦的敏感率>90%。
- 96%(74/77)的分离株对莫西沙星耐药。
- Mayo Clinic Rochester患者平均年龄55岁(标准差17),女性9例(35%),所有患者血流感染时均中性粒细胞减少。
- 感染主要来源为胃肠道(58%)、血管内导管(35%)和牙源性(15%)。
关键数值与推荐
- Leptotrichia菌种对青霉素、甲硝唑、厄他培南和哌拉西林-他唑巴坦敏感率>90%。
- 96%(74/77)的分离株对莫西沙星耐药。
- 60天全因死亡率为19%,无微生物学复发。
临床怎么用
- 对于中性粒细胞减少患者,应警惕Leptotrichia血流感染的可能。
- 选择抗菌治疗时,应参考药敏试验结果,尤其注意莫西沙星耐药率高。
- 常见感染来源包括胃肠道、血管内导管和牙源性,需相应评估和处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Leptotrichia species are anaerobic, Gram-negative bacilli increasingly recognized as pathogens capable of causing invasive infections such as bloodstream infection (BSI), particularly among immunocompromised patients. However, there is a paucity of data regarding epidemiology, antimicrobial susceptibility, optimal treatment, and clinical outcomes among patients with Leptotrichia bacteremia. Patient risk factors, treatment approaches, and outcomes of a retrospective cohort of adult patients with Leptotrichia BSI at a tertiary medical center (Mayo Clinic Rochester [MCR]) were evaluated. Concurrently, species, temporal trends, and antimicrobial susceptibility testing (AST) results of Leptotrichia isolates submitted to a reference laboratory (Mayo Clinic Laboratories) over the past 10 years were examined. We identified 224 blood culture isolates of Leptotrichia species, with 26 isolates from patients treated at MCR. The most frequent species included L. trevisanii (49%), L. buccalis (24%), and L. wadei (16%). Leptotrichia species demonstrated >90% susceptibility to penicillin, metronidazole, ertapenem, and piperacillin-tazobactam. However, 96% (74/77) of isolates were resistant to moxifloxacin. For patients treated at MCR, the mean patient age was 55 years (standard deviation [SD], 17), with 9 females (35%), and all were neutropenic at the time of BSI. The primary sources of infection were gastrointestinal (58%), intravascular catheter (35%), and odontogenic (15%). Patients were treated with metronidazole (42%), piperacillin-tazobactam (27%), or carbapenems (19%). The mean duration of treatment was 11 days (SD, 4.5), with a 60-day all-cause mortality of 19% and no microbiologic relapse. Leptotrichia species are rare but important causes of BSI in neutropenic patients. Due to evolving antimicrobial susceptibility profiles, a review of AST results is necessary when selecting optimal antimicrobial therapy.
引用
- Ranganath N, Shirley JD, Challener DW, et al. Leptotrichia Bacteremia: 10-Year Retrospective Clinical Analysis and Antimicrobial Susceptibility Profiles. J Clin Microbiol. 2023. PMID: 36715514. doi:10.1128/jcm.01733-22
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。